The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults

NCT02225600 · clinicaltrials.gov ↗

NA

Phase

SUSPENDED

Status

40

Enrollment

OTHER

Sponsor class

Stopped Avoiding intranasal spray durng COVID

Conditions

Borderline Personality Disorder

Interventions

DRUG: 40 IU Intranasal Oxytocin
DRUG: Placebo
DRUG: 24 IU intranasal Oxytocin

Sponsor

Icahn School of Medicine at Mount Sinai